I personally think that any of the big pharma companies would want to own the rights to this molecule and the only way to get there would be a buyout. Unfortunately for them they should have made this move along time ago before this pandemic has brought light to the many many possibilities of Leronlimab. Now when CYDY had potential for the future, I"m sure they are throwing numbers at the wall hoping one will stick. I think ther future may depend on it and I believe at this point, and as each day grows closer to an approved molecule the price of tea in China (No pun intended) is going up and up to the point of a potential reverse buyout. One mans opinion!